<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">helmholtzeyeinstitute</journal-id><journal-title-group><journal-title xml:lang="ru">Российский офтальмологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Ophthalmological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0076</issn><issn pub-type="epub">2587-5760</issn><publisher><publisher-name>Real time Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21516/2072-0076-2023-16-3-81-86</article-id><article-id custom-type="elpub" pub-id-type="custom">helmholtzeyeinstitute-1303</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Цитомегаловирусный увеит у ВИЧ-инфицированных: основные клинические формы</article-title><trans-title-group xml:lang="en"><trans-title>Cytomegalovirus uveitis in HIV-infected patients: the main clinical forms</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сизова</surname><given-names>Т. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Sizova</surname><given-names>T. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Татьяна Дмитриевна Сизова - врач-офтальмолог, аспирант</p><p>наб. Обводного канала, 179, Санкт-Петербург, 190103</p><p>Заневский пр-т, д. 1/82, Санкт-Петербург, 195196</p></bio><bio xml:lang="en"><p>Tatiana D. Sizova - ophthalmologist, PhD student</p><p>179, Obvodny Canal Emb., St. Petersburg, 190103</p><p>1/82, Zanevsky Ave, St. Petersburg</p></bio><email xlink:type="simple">tanja_sizova@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хокканен</surname><given-names>В. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Khokkanen</surname><given-names>V. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Валентина Михайловна Хокканен - д-р мед. наук, профессор, профессор кафедры офтальмологии</p><p>Заневский пр-т, д. 1/82, Санкт-Петербург, 195196</p></bio><bio xml:lang="en"><p>Valentina M. Khokkanen - Dr. of Med. Sci., professor, professor of chair of ophthalmology</p><p>1/82, Zanevsky Ave, St. Petersburg</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бойко</surname><given-names>Э. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Boiko</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Эрнест Витальевич Бойко - д-р мед. наук, профессор, заведующий кафедрой офтальмологии, член-корреспондент, директор</p><p>Заневский пр-т, д. 1/82, Санкт-Петербург, 195196</p><p>ул. Академика Лебедева, д. 37, Санкт-Петербург, 195009</p><p>ул. Я. Гашека, д. 21, Санкт-Петербург, 192283</p></bio><bio xml:lang="en"><p>Ernest V. Boiko - Dr. of Med. Sci., professor, head of chair of ophthalmology, corresponding member</p><p>1/82, Zanevsky Ave, St. Petersburg, 195196</p><p>37, Academician Lebedev St., St. Petersburg, 195009</p><p>21, Hashek St., St. Petersburg, 192283</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>СПб ГБУЗ «Центр по профилактике и борьбе со СПИД и инфекционными заболеваниями»; ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>St. Petersburg Center for Control of AIDS and Infectious Diseases; I.I. Mechnikov North-Western State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.I. Mechnikov North-Western State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова»; Военно-медицинская академия им. С.М. Кирова, ул. Академика Лебедева; СПб филиал ФГАУ НМИЦ «МНТК "Микрохирургия глаза" им. акад. С.Н. Федорова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.I. Mechnikov North-Western State Medical University; S.M. Kirov Military Medical Academy; St. Petersburg Branch of the S.Fyodorov Eye Microsurgery Federal State Institution</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>11</day><month>10</month><year>2023</year></pub-date><volume>16</volume><issue>3</issue><fpage>81</fpage><lpage>86</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сизова Т.Д., Хокканен В.М., Бойко Э.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Сизова Т.Д., Хокканен В.М., Бойко Э.В.</copyright-holder><copyright-holder xml:lang="en">Sizova T.D., Khokkanen V.M., Boiko E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://roj.igb.ru/jour/article/view/1303">https://roj.igb.ru/jour/article/view/1303</self-uri><abstract><p>Эффективное лечение ВИЧ-инфицированных пациентов изменило представление о клинической картине цитомегаловирусного увеита (ЦМВ-увеита).Цель работы - определить частоту и структуру клинических форм ЦМВ-увеита у ВИЧ-инфицированных пациентов.Материал и методы. Обследовано 66 пациентов (97 глаз) в возрасте 39,6 ± 3,91 года. У всех больных зарегистрирована IVв-стадия ВИЧ-инфекции, давность инфицирования больных превышала 5 лет у 35 (53%) пациентов, более 10 лет — у 13 (19,7%), более 15 лет — у 13 (19,7%). Длительность наблюдения у офтальмолога с диагнозом «ЦМВ-увеит» варьировала от 6 мес до 13 лет (медиана — 45,5 мес).Результаты. К моменту выявления ЦМВ-увеита медиана количества CD4-лимфоцитов составила 34 кл/мкл (при норме 570–1100 кл/мкл). Содержание ДНК ЦМВ в цельной крови составило 2,43 lg копий/105 клеток. Основной формой заболевания являлся хориоретинит, в 68,0% случаев диагностированы диффузные и генерализованные формы заболевания. При прогнозировании остроты зрения ведущим регрессионным критерием являлась клиническая форма заболевания.Заключение. В клинической практике преобладали диффузные и генерализованные формы заболевания. Распространенность хориоретинального поражения предопределяла остроту зрения, которая у 39,2% глаз соответствовала критериям слепоты по классификации ВОЗ (1977).</p></abstract><trans-abstract xml:lang="en"><p>Effective treatment of HIV-infected patients has changed the previous view of the clinical picture of cytomegalovirus uveitis (CMV uveitis).Purpose: to determine the prevalence and structure of clinical forms of CMV uveitis in HIV-infected patients.Material and methods. 66 patients (97 eyes), aged 39.6 ± 3.91, were diagnosed with stage 4c HIV infection. In 35 patients (53%), the duration of infection exceeded 5 years, in 13 patients (19.7%), it exceeded 10 years, and another 13 patients (19.7%) had the condition for over 15 years. The ophthalmological follow-up of patients diagnosed with CMV uveitis ranged from 6 months to 13 years (the median of 45.5 months).Results. By the time CMV uveitis was detected, the median CD4 cell count was 34 cells/μL (the norm being 570–1100 cells/μL). The content of whole blood CMV DNA was 2.43 lg copies/105 cells. The main form of the disease was chorioretinitis, diffuse and generalized forms of the disease were diagnosed in 68.0% of cases. In predicting visual acuity, the leading regression criterion was the clinical form of the disease.Conclusion. Diffuse and generalized forms of the disease prevailed in clinical practice. The prevalence of chorioretinal lesion determined visual acuity, which in 39.2% of the eyes met the criteria for blindness according to the WHO classification (1977)</p></trans-abstract><kwd-group xml:lang="ru"><kwd>цитомегаловирусный ретинит</kwd><kwd>вирус иммунодефицита человека</kwd><kwd>ВИЧ</kwd><kwd>ВИЧ-инфекция</kwd><kwd>оппортунистические заболевания</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cytomegalovirus retinitis</kwd><kwd>human immunodeficiency virus (HIV)</kwd><kwd>HIV infection</kwd><kwd>opportunistic disease</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Покровский В.В., ред. ВИЧ-инфекция: клиника, диагностика, лечение. Москва: ГЭОТАР- Медиа; 2003.</mixed-citation><mixed-citation xml:lang="en">Pokrovskij V.V., ed. HIV-infection: clinic, diagnosis, treatment. Mosсow: GEOTAR-Media; 2003 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Информационный бюллетень — Глобальная статистика по ВИЧ.</mixed-citation><mixed-citation xml:lang="en">Global HIV AIDS statistics — Fact sheet (In Russ.). Available at: https://www.unaids.org/ru/resources/fact-sheet/ (accessed 28 Apr 2022).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Государственный доклад «О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2020 году».</mixed-citation><mixed-citation xml:lang="en">State Report «On the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2020» (In Russ.). Available at: https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=18266/ (accessed 28 Apr 2022).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Справка «ВИЧ-инфекция в Российской Федерации на 30 сентября 2021 г.». Федеральный научно-методический центр по профилактике и борьбе со СПИДом ФБУН ЦНИИ эпидемиологии Роспотребнадзора, Москва; 2021.</mixed-citation><mixed-citation xml:lang="en">Reference “HIV infection in the Russian Federation as of September 30, 2021” (In Russ.. Available at: http://www.hivrussia.info/wp-content/uploads/2022/03/Spravka-VICH-v-Rossii-na-31.12.2021-g.pdf/ (accessed 28 Apr 2022).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Приказ Министерства здравоохранения РФ от 8 ноября 2012 г. № 689н «Об утверждении порядка оказания медицинской помощи взрослому населению при заболевании, вызываемом вирусом иммунодефицита человека (ВИЧ-инфекции)»</mixed-citation><mixed-citation xml:lang="en">Order of the Ministry of Health of the Russian Federation № 689n dated November 8, 2012. “On approval of the procedure for providing medical care to adults with a disease caused by the human immunodeficiency virus (HIV infection)” (In Russ.). Available at: https:// minzdrav.gov.ru/documents/9155-prikaz-ministerstva-zdravoohraneniyarossiyskoy-federatsii-ot-8-noyabrya-2012-g-689n-ob-utverzhdenii-poryadkaokazaniya-meditsinskoy-pomoschi-vzroslomu-naseleniyu-pri-zabolevaniivyzyvaemom-virusom-immunodefitsita-cheloveka-vich-infektsii/ (accessed 28 Apr. 2022).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Онищенко А.Л., Колбаско А.В., Татарникова Г.Н., Гребенчук О.С. Отслойка сетчатки у ВИЧ-инфицированных пациентов с цитомегаловирусным ретинитом. Вестник офтальмологии. 2014; 130 (3): 42–4.</mixed-citation><mixed-citation xml:lang="en">Onischenko A.L., Kolbasko A.V., Tatarnikova G.N., Grebenchuk O.S. Retinal detachment in HIV-infected patients with cytomegalovirus retinitis. Vestnik ofthal’mologii. 2014; 130 (30): 42–4 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kempen JH, Sugar EA, Lyon AT, et al. Studies of ocular complications of AIDS Research Group. Risk of cataract in persons with cytomegalovirus retinitis and the acquired immune deficiency syndrome. Ophthalmology. 2012; 119 (11): 2343–50. doi: 10.1016/j.ophtha.2012.05.044</mixed-citation><mixed-citation xml:lang="en">Kempen JH, Sugar EA, Lyon AT, et al. Studies of ocular complications of AIDS Research Group. Risk of cataract in persons with cytomegalovirus retinitis and the acquired immune deficiency syndrome. Ophthalmology. 2012; 119 (11): 2343–50. doi: 10.1016/j.ophtha.2012.05.044</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Cassoux N, Lumbroso L, Bodaghi B, et al. Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy. Br J Ophthalmol. 1999; 83 (1): 47–9. doi: 10.1136/bjo.83.1.47</mixed-citation><mixed-citation xml:lang="en">Cassoux N, Lumbroso L, Bodaghi B, et al. Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy. Br J Ophthalmol. 1999; 83 (1): 47–9. doi: 10.1136/bjo.83.1.47</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Хижняк Т.В., Астахов Ю.С., Рахманова А.Г. К вопросу о ранней диагностике ЦМВ-ретинита у больных ВИЧ-инфекцией. Офтальмологические ведомости. 2011; 4 (2): 39–45.</mixed-citation><mixed-citation xml:lang="en">Khizhnyak T.V., Astakhov Yu.S., Rahmanova A.G. On the issue of early diagnosis of CMV retinitis in patients with HIV infection. Ophthalmology journal. 2011; 4 (2): 39–45 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Онищенко А.Л., Колбаско А.В., Татарникова Г.Н., Чернышева А.Д. Лечение отслойки сетчатки у ВИЧ-инфицированных пациентов с цитомегаловирусным ретинитом. Офтальмология. 2017; 14 (1): 84–7.</mixed-citation><mixed-citation xml:lang="en">Onischenko A.L., Kolbasko A.V., Tatarnikova G.N., Chernysheva A.D. Treatment of retinal detachment in HIV-infected patients with cytomegalovirus retinitis. Ophthalmology in Russia. 2017; 14 (1): 84–7 (In Russ.). doi: 10.18008/1816-5095-2017-1-84-87</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Гаврилова Т.В., Сергиенко А.П., Черешнева М.В., Собянина А.Н. Поражение органа зрения при терминальной стадии ВИЧ-инфекции. Клинический случай. Офтальмология. 2021; 18 (2): 368–73.</mixed-citation><mixed-citation xml:lang="en">Gavrilova T.V., Sergienko A.P., Chereshneva M.V., Sobianina A.N. Damage to the organ of vision in the terminal stage of HIV infection. A clinical case. Ophthalmology in Russia. 2021; 18 (2): 368–73 (In Russ.). doi:10.18008/1816-5095-2021-2-368-373</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Сизова Т.Д., Хокканен В.М., Гусев Д.А., Бойко Э.В. Цитомегаловирусный увеит у ВИЧ-инфицированных пациентов: течение и исходы. Журнал инфектологии. 2020; 12 (4): 45–50.</mixed-citation><mixed-citation xml:lang="en">Sizova T.D., Khokkanen V.M., Gusev D.A., Boiko E.V. Cytomegalovirus uveitis in HIV-infected patients: course and outcomes. Journal infectiology. 2020; 12 (4): 45–50 (In Russ.). doi: 10.22625/2072-6732-2020-12-4-45-50</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ando Y, Terao K, Narita M., et al. Quantitative analyses of cytomegalovirus genome in aqueous humor of patients with cyto-megalovirus retinitis. Jpn J Ophthalmol. 2002; 46 (3): 254–60. doi: 10.1016/s0021-5155(01)00524-x</mixed-citation><mixed-citation xml:lang="en">Ando Y, Terao K, Narita M., et al. Quantitative analyses of cytomegalovirus genome in aqueous humor of patients with cyto-megalovirus retinitis. Jpn J Ophthalmol. 2002; 46 (3): 254–60. doi: 10.1016/s0021-5155(01)00524-x</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Chen C, Guo CG, Meng L, et al. Comparative analysis of cytomegalovirus retinitis and microvascular retinopathy in patients with acquired immunodeficiency syndrome. Int. J. Ophthalmol. 2017; 10 (9): 1396–401. doi: 10.18240/ijo.2017.09.11</mixed-citation><mixed-citation xml:lang="en">Chen C, Guo CG, Meng L, et al. Comparative analysis of cytomegalovirus retinitis and microvascular retinopathy in patients with acquired immunodeficiency syndrome. Int. J. Ophthalmol. 2017; 10 (9): 1396–401. doi: 10.18240/ijo.2017.09.11</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Tang S, Zhao N, Wang LY, Wen Y. Frosted branch angiitis due to cytomegalovirus-associated unmasking immune reconstitution inflammatory syndrome: a case report and literature review. BMC Infect. Dis. 2021; 21 (1): 613. doi: 10.1186/s12879-021-06311-4</mixed-citation><mixed-citation xml:lang="en">Tang S, Zhao N, Wang LY, Wen Y. Frosted branch angiitis due to cytomegalovirus-associated unmasking immune reconstitution inflammatory syndrome: a case report and literature review. BMC Infect. Dis. 2021; 21 (1): 613. doi: 10.1186/s12879-021-06311-4</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Li W, Wang X, Zhao L, et al. The value and implementation of routine ophthalmic examination in the era of HAART. EClinicalMedicine. 2020; 31: 100646. doi: 10.1016/j.eclinm.2020.100646</mixed-citation><mixed-citation xml:lang="en">Li W, Wang X, Zhao L, et al. The value and implementation of routine ophthalmic examination in the era of HAART. EClinicalMedicine. 2020; 31: 100646. doi: 10.1016/j.eclinm.2020.100646</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Heiden D, Tun N, Smithuis FN., et al. Active cytomegalovirus retinitis after the start of antiretroviral therapy. Br J Ophthalmol. 2019; 103 (2): 157–60. doi: 10.1136/bjophthalmol-2018-312406</mixed-citation><mixed-citation xml:lang="en">Heiden D, Tun N, Smithuis FN., et al. Active cytomegalovirus retinitis after the start of antiretroviral therapy. Br J Ophthalmol. 2019; 103 (2): 157–60. doi: 10.1136/bjophthalmol-2018-312406</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Sugar EA, Jabs DA, Ahuja A, et al. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol. 2012; 153 (6): 1016–24. doi: 10.1016/j.ajo.2011.11.014</mixed-citation><mixed-citation xml:lang="en">Sugar EA, Jabs DA, Ahuja A, et al. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol. 2012; 153 (6): 1016–24. doi: 10.1016/j.ajo.2011.11.014</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Chakraborty A, Mahapatra T, Mahapatra S, et al. Distribution and determinants of cytomegalovirus induced end organ disease/s among people living with HIV/ AIDS in a poor resource setting: observation from India. PLoS One. 2015; 10 (2): e0117466. doi: 10.1371/journal.pone.0117466</mixed-citation><mixed-citation xml:lang="en">Chakraborty A, Mahapatra T, Mahapatra S, et al. Distribution and determinants of cytomegalovirus induced end organ disease/s among people living with HIV/ AIDS in a poor resource setting: observation from India. PLoS One. 2015; 10 (2): e0117466. doi: 10.1371/journal.pone.0117466</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Максимов В.Ю., Дмитриева О.Г., Евсеев С.Ю., Александрова Н.М. Диагностика и лечение увеитов герпес-вирусной и хламидийной этиологии. РМЖ. Клиническая офтальмология. 2003; 4 (4): 168.</mixed-citation><mixed-citation xml:lang="en">Maksimov V.Yu., Dmitrieva O.G., Evseev S.Yu., Aleksandrova N.M. Diagnosis and treatment of uveitis of herpesvirus and chlamydia etiology. RMZh. Klinicheskaja oftal'mologija. 2003; 4 (4): 168 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Кацнельсон Л.А., Танковский В.Э. Увеиты (клиника, лечение). Москва: 4-й филиал Воениздата; 2003.</mixed-citation><mixed-citation xml:lang="en">Kacnel'son L.A., Tankovskij V.E. Uveitis (clinic, treatment). Moscow: 4-yj filial Voenizdata; 2003 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005; 140 (3): 509–16. doi: 10.1016/j.ajo.2005.03.057</mixed-citation><mixed-citation xml:lang="en">Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005; 140 (3): 509–16. doi: 10.1016/j.ajo.2005.03.057</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Федеральные клинические рекомендации «Неинфекционные увеиты у взрослых. Москва; 2019.</mixed-citation><mixed-citation xml:lang="en">Federal clinical guidelines “Non-infectious uveitis in adults. Moscow; 2019” (In Russ.). Available at: https://oor.ru/files/uveity/uveity.pdf (accessed 09 Jul 2022).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
